Abstract
Background:
Diet is a modulator of inflammation and may impact inflammatory skin diseases.
Objective:
To assess the relationship between pro-inflammatory dietary patterns and incident psoriasis, psoriatic arthritis (PsA), and atopic dermatitis (AD).
Methods:
We conducted cohort studies among women in the Nurses’ Health Study II. The empirical dietary inflammatory pattern (EDIP) score was calculated at baseline and every four years. Incident psoriasis, PsA, and AD were assessed by validated self-report. We used multivariable-adjusted Cox proportional hazards models to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between EDIP quintiles and risk of psoriasis, PsA and AD.
Results:
We had 85,185 participants in the psoriasis analysis and 63,443 in the AD analysis. There were 1,432 cases of psoriasis, 262 cases of PsA and 403 cases of AD. Pro-inflammatory dietary patterns were not associated with risk of the outcomes in multivariable models (all P-trend > 0.05). HRs comparing the highest to the lowest EDIP quintile were 0.99 (95% CI 0.83 – 1.18) for psoriasis, 1.22 (0.81 – 1.83) for PsA and 0.96 (0.69 – 1.34) for AD.
Limitations:
Recall and self-report.
Conclusions:
Our findings do not support dietary inflammatory potential as a risk factor for psoriasis, PsA or AD.
Keywords: psoriasis, psoriatic arthritis, atopic dermatitis, inflammatory diet, NHS-II, CRP, IL-6, TNF-α, EDIP
Introduction
Psoriasis and atopic dermatitis are chronic immune-mediated, inflammatory skin conditions affecting 3%1, 2 and 5 – 7%3, 4 of the US adult population, respectively. Psoriatic arthritis, a seronegative spondyloarthropathy, is present in up to 30% of patients with psoriasis.5 While intrinsic immunological processes play a role in the pathogenesis of these conditions,6–8 there are well-recognized factors such as obesity,9–11 smoking,12–15 and stress16, 17 that may modulate the risk, severity, and prognosis of these inflammatory conditions.
Diet is a modifiable factor implicated in chronic systemic inflammation18–20 and in the development and progression of several chronic diseases.21–24 Recent meta-analyses highlight the anti-inflammatory benefit of the Mediterranean diet with reductions of circulating C-reactive protein (CRP), interleukin-6 (IL-6), and adiponectin concentrations25 in addition to decreased risk of diabetes26 and cancer mortality,27, 28 both of which have known pro-inflammatory pathologies.29–33 The Empirical Dietary Inflammatory Pattern (EDIP) is a recently developed and validated measure;34 dietary patterns with high EDIP scores are associated with higher levels of tumor necrosis factor alpha (TNF-α), TNF-α R1, TNF-α R2, CRP, IL-6, and adiponectin.34–36 Psoriasis and psoriatic arthritis are Th1- and Th17-mediated diseases with increased serum levels of IL-6, CRP, and TNF-α37 – biomarkers of systemic inflammation that are also elevated in other chronic inflammatory diseases such as diabetes,38 cardiovascular disease,39, 40 and inflammatory bowel disease.41 In contrast to psoriasis and psoriatic arthritis, atopic dermatitis is primarily a Th2-mediated skin disease with lesser involvement of Th1/Th17 inflammatory cytokines.42
Although many patients wonder whether an anti-inflammatory diet can decrease their risk of inflammatory skin disease, patients and clinicians have limited evidence on which to base ensuing discussions. The objective of our study was to assess whether pro-inflammatory dietary patterns increase the risk of incident psoriasis, psoriatic arthritis, and atopic dermatitis in a large cohort of US women. We hypothesized that consumption of a pro-inflammatory diet, as measured by higher EDIP scores, would increase the risk of developing psoriasis and psoriatic arthritis. Given the divergent inflammatory mechanisms underlying psoriatic disease and atopic dermatitis, we expected the relationship between EDIP score and atopic dermatitis to be null.
Materials & Methods
Study population
The Nurses’ Health Study II (NHS-II) is a large prospective cohort study started in 1989 with 116,430 US female nurses aged 25 – 42 years. Data on risk factors and diseases are collected by questionnaire biennially.
Assessment of diet and calculation of EDIP scores
In NHS-II, food frequency questionnaires are administered every four years starting from 1991. The development of the EDIP score in a sample of 5230 women in the Nurses’ Health Study has been described elsewhere.34 In brief, the EDIP is an empirical score of the overall inflammatory potential of diets using food groups that were most predictive of 3 plasma markers of inflammation: IL-6, CRP, and TNF-αR2. The EDIP score is the weighted sum of 18 food groups maximally anti-inflammatory (lower scores) to maximally proinflammatory (higher scores). The EDIP score has been validated34 and has a higher ability to predict concentrations of CRP, TNF-α, and adiponectin than nutrient-based dietary inflammatory indices.35
The following food groups comprising the EDIP score are positively related to inflammatory marker concentrations (i.e. “pro-inflammatory”): processed meat, red meat, organ meat, white fish, vegetables other than green leafy vegetables and dark yellow vegetables, refined grains, high-energy beverages (cola and other carbonated beverages with sugar, fruit drinks), low-energy beverages (low-energy cola and other low-energy carbonated beverages), and tomatoes. The following food groups are inversely related to inflammatory marker concentrations (i.e. “anti-inflammatory”): beer, wine, tea, coffee, dark yellow vegetables, green leafy vegetables, snacks (i.e. popcorn, crackers), fruit juice, and pizza.34 Some of these groupings are counter-intuitive and apparently contradictory, but this can be explained by the differential nutritional content of related foods. For example, fresh tomatoes have a low content of bioavailable lycopene (a major anti-inflammatory nutrient)43 compared to 2–5 times higher concentrations in cooked tomato paste.44 Furthermore, pizza typically contains large amounts of high fat dairy which have anti-inflammatory and low insulinemic properties.45 This explains why pizza is grouped as anti-inflammatory while tomatoes are not. As the goal of the EDIP score is to account for the overall effect of dietary patterns, only food groups that explain maximal variation in the three noted inflammatory biomarkers are retained for analysis.
Diagnosis of psoriasis and psoriatic arthritis
Participants were asked whether they were ever diagnosed with psoriasis by a clinician periodically during cohort follow-up. Participants were asked the year of diagnosis in intervals when assessed in 2005 (before 1991, 1991 – 1994, 1995 – 1998, 1999 – 2002, and 2003+), 2009 (before 1995, 1995 – 1999, 2000 – 2004, 2005 – 2006, and 2007+), and 2013 (before 1995, 1995 – 2002, 2003 – 2008, 2009 – 2010, and 2011+). Psoriasis reports were confirmed using the Psoriasis Screening Tool (PST) questionnaire to confirm cases of psoriasis with 94% specificity.47 Participants completing the PST were also asked the specific year in which their psoriasis was diagnosed. Participants with psoriasis were asked whether they had been diagnosed with psoriatic arthritis, with reports validated using the Psoriatic Arthritis Screening and Evaluation (PASE) questionnaire with 73–80% specificity.48 Only validated cases of psoriasis and psoriatic arthritis are counted as incident cases in our analyses.
Diagnosis of atopic dermatitis
Atopic dermatitis was assessed by self-report in 2013. Patients were asked if they ever received a diagnosis of ‘eczema (atopic dermatitis)’ by a clinician and what year they were diagnosed, in intervals (before 1995, 1995 – 2002, 2003 – 2008, 2009 – 2010, and 2011 +). In 2017, women who had reported a diagnosis of atopic dermatitis were sent a supplemental questionnaire asking them to reaffirm their self-report and answer related questions.49 Questions from that supplemental questionnaire are used in two separate algorithms to confirm a diagnosis of atopic dermatitis with ≥ 84% specificity.50 Our primary atopic dermatitis case definition (definition 1) included women who reaffirmed their self-report on the supplemental questionnaire. In sensitivity analyses, we applied the two validated algorithms to enhance the specificity of the diagnosis (definitions 2 and 3).
Assessment of covariates
At cohort baseline (1989), participants were asked their height and race/ethnicity. Biennially, participants were asked about their weight, smoking status, physical activity and diagnoses of hypercholesterolemia, type 2 diabetes, cardiovascular disease, and asthma.
Statistical analysis
We excluded participants with unknown birth years. For the psoriasis/psoriatic arthritis analysis, participants were excluded if they: 1) had died before 1991, 2) had prevalent psoriasis at baseline in 1991, or 3) reported having psoriasis, but without confirmation during validation. For the atopic dermatitis analysis, participants were excluded if they: 1) had died before 1995, 2) had prevalent atopic dermatitis at baseline in 1995, or 3) reported atopic dermatitis on the main questionnaire but did not have their report confirmed during validation. Participants were also asked about a history of atopic dermatitis in 2009 without year of diagnosis; patients who reported having atopic dermatitis in 2009 but not in 2013 were excluded – 3589 for self-reported atopic dermatitis, and 352 from the validation study. In total, 85,185 patients were included in the psoriasis and psoriatic arthritis analysis, and 63,443 patients were included in the atopic dermatitis analysis.
We calculated person-years of follow-up from the return date of the baseline questionnaire for each analysis until the date of death, diagnosis of psoriasis, psoriatic arthritis or atopic dermatitis, respectively, or end of follow up (2013), whichever was earliest. The date of diagnosis of skin disease was considered the specific year of diagnosis, if available, or the middle value of the given range of diagnosis years.
EDIP scores were calculated as the cumulative average score from all reports up to the start of each two-year follow-up interval to best represent habitual long-term dietary intake and reduce within-person variation. Due to the high within-person correlations in EDIP scores between adjacent data cycles, we carried forward non-missing dietary intake data from the previous data cycle to replace any missing data in the next cycle. Covariate data were treated similarly.
We used Cox proportional hazards models to calculate age- and multivariable-adjusted hazard ratios (HR) with 95% confidence intervals (CI) for the association of EDIP quintiles with the risk of developing incident psoriasis, psoriatic arthritis and atopic dermatitis. We tested the proportional hazards assumption and found it was not violated for any of the outcomes (all P>0.05). Covariates adjusted for in the main multivariable model (multivariable model 1) included age, race (Caucasian vs. non-Caucasian), BMI (kg/m2), smoking (never smoker, past smoker, current smoker 1 – 14 cigarettes per day (CPD), 15 – 25 CPD, and 25+ CPD), alcohol intake (0 g/d, 0.1 – 4.9 g/d, 5.0 – 9.9 g/d, and 10+ g/d), calorie consumption (kcal/day in quintiles), and exercise (METs/week in quintiles). The second multivariable model (multivariable model 2) included all of the above covariates in addition to comorbid cardiovascular disease, hypertension, hypercholesterolemia, and type 2 diabetes. For atopic dermatitis, we also used a third multivariable model (multivariable model 3) additionally adjusting for a history of asthma. Further, for atopic dermatitis analyses, we conducted stratified analyses of multivariable models 1 and 2 by comorbid asthma. For each of the analyses, P for trend was calculated using the median EDIP score within each quintile.
All statistical analysis was performed with SAS, version 9.2 (SAS Institute, Inc., Cary, NC). A two-tailed P <0.05 was considered statistically significant.
Results
We had 85,185 participants in the psoriatic disease analysis and 63,443 participants in the atopic dermatitis analysis. Baseline characteristics of participants in the psoriasis analysis according to EDIP quintile are presented in Table I. Participants with higher EDIP scores generally had higher BMI, lower physical activity and alcohol consumption and higher rates of hypercholesterolemia and hypertension. Similar patterns were seen in the baseline characteristics of participants included in the atopic dermatitis analysis with the addition that asthma was somewhat more common with higher EDIP scores.
Table I.
Characteristics of Nurses’ Health Study II participants by baseline EDIP score in quintiles
| Quintiles of total EDIP score | |||||
|---|---|---|---|---|---|
| Characteristic | Q1 | Q2 | Q3 | Q4 | Q5 |
| Psoriatic disease cohort (1991) | |||||
| Number of participants | 17,037 | 17,037 | 17,037 | 170,37 | 17,037 |
| Age (years)* in 1991 | 37 ± 4 | 37 ± 5 | 36 ± 5 | 36 ± 5 | 35 ± 5 |
| EDIP score | −477 ± 214 | −174 ± 52 | −18 ± 42 | 140 ± 53 | 465 ± 217 |
| White race (%) | 98 | 97 | 96 | 95 | 94 |
| Body mass index (kg/m2) | 24 ± 4 | 24 ± 5 | 24 ± 5 | 25 ± 5 | 26 ± 6 |
| Physical activity level (metabolic-equivalents h/wk.) | 25 ± 32 | 22 ± 27 | 20 ± 26 | 19 ± 25 | 18 ± 25 |
| Total energy intake (kcal/d) | 1802 ± 54 | 1693 ± 508 | 1694 ± 509 | 1771 ± 528 | 1999 ± 581 |
| Alcohol intake (g/d) | 6 ± 9 | 3 ± 5 | 3 ± 5 | 2 ± 4 | 2 ± 5 |
| Current smoking (%) | 15 | 11 | 10 | 9 | 12 |
| Comorbid cardiovascular disease (%) | <1 | <1 | <1 | <1 | <1 |
| Comorbid type 2 diabetes (%) | <1 | <1 | <1 | <1 | <1 |
| Comorbid hypertension (%) | 5 | 5 | 6 | 7 | 9 |
| Comorbid hypercholesterolemia (%) | 13 | 13 | 14 | 15 | 18 |
| Atopic dermatitis cohort (1995) | |||||
| Number of participants | 12,688 | 12,689 | 12,689 | 12,689 | 12,688 |
| Age (years)* in 1995 | 42 ± 4 | 41 ± 5 | 40 ± 5 | 40 ± 5 | 40 ± 5 |
| EDIP score | −406 ± 174 | −149 ± 45 | −9 ± 38 | 135 ± 48 | 429 ± 193 |
| White race (%) | 98 | 97 | 96 | 95 | 94 |
| Body mass index (kg/m2) | 24 ± 5 | 25 ± 5 | 25 ± 6 | 26 ± 6 | 28 ± 7 |
| Physical activity level (metabolic-equivalents h/wk.) | 25 ± 30 | 22 ± 29 | 21 ± 25 | 19 ± 24 | 18 ± 25 |
| Total energy intake (kcal/d) | 1780 ± 532 | 1721 ± 519 | 1741 ± 524 | 1811 ± 547 | 2006 ± 586 |
| Alcohol intake (g/d) | 7 ± 10 | 4 ± 6 | 3 ± 5 | 2 ± 5 | 2 ± 4 |
| Current smoking (%) | 13 | 10 | 8 | 8 | 10 |
| Comorbid cardiovascular disease (%) | <1 | <1 | <1 | <1 | <1 |
| Comorbid type 2 diabetes (%) | <1 | <1 | <1 | 1 | 1 |
| Comorbid hypertension (%) | 7 | 7 | 8 | 10 | 13 |
| Comorbid hypercholesterolemia (%) | 17 | 18 | 20 | 23 | 26 |
| Comorbid asthma (%) | 8 | 8 | 9 | 9 | 10 |
Values are means (SD) or percentages and are standardized to the age distribution of the study population.
Value is not age-adjusted
There were 1,425 cases of psoriasis over 2,014,487 person-years and 262 cases of psoriatic arthritis over 2,030,235 person-years. There was no association between pro-inflammatory diet and incident psoriasis in the age- or multivariable-adjusted models (all P-trend >0.05) (Table II). For psoriatic arthritis, a direct association was seen between high EDIP scores (quintile 5 vs quintile 1: 1.67 [95% CI 1.14 – 2.45], p-trend = 0.007) in the age-adjusted analysis, but this was no longer significant in multivariable model 1 (quintile 5 vs quintile 1: 1.22 [95% CI 0.81 – 1.83], p-trend = 0.54), or multivariable model 2 (quintile 5 vs quintile 1: 1.17 [95% CI 0.77 – 1.76], p-trend = 0.70). To assess reasons for attenuation of the association with psoriatic arthritis in the multivariable models, we conducted analyses with EDIP as the exposure, psoriatic arthritis as the outcome and age plus each individual covariate individually in separate models. We found that BMI was largely responsible for the attenuation. To assess possible effect modification by BMI, we then conducted age- and multivariable-adjusted analyses stratified by BMI (<25, ≥25 kg/m2), with further adjustment for BMI as a continuous variable within each stratum. There was no significant difference between the BMI strata (p for interaction = 0.94); results are shown in Table III.
Table II.
Risk of psoriasis and psoriatic arthritis according to quintiles of EDIP score in Nurses’ Health Study II
| EDIP | Person-years | # of cases | Age-adjusted HR (95% CI) | MV-adjusted HR1 (95% CI)† | MV-adjusted HR2 (95% CI)‡ |
|---|---|---|---|---|---|
| Psoriasis | |||||
| Q1 | 402,913 | 298 | 1 [reference] | 1 [reference] | 1 [reference] |
| Q2 | 403,114 | 276 | 0.94 [0.80 – 1.11] | 0.96 [0.81 – 1.13] | 0.96 [0.81 – 1.13] |
| Q3 | 402,684 | 269 | 0.93 [0.78 – 1.09] | 0.95 [0.80 – 1.12] | 0.94 [0.79 – 1.12] |
| Q4 | 402,999 | 283 | 0.98 [0.83 – 1.15] | 0.98 [0.82 – 1.16] | 0.97 [0.81 – 1.15] |
| Q5 | 402,776 | 306 | 1.07 [0.91 – 1.26] | 0.99 [0.83 – 1.18] | 0.97 [0.82 – 1.16] |
| P for trend | 0.31 | 0.85 | 0.67 | ||
| Psoriatic Arthritis | |||||
| Q1 | 406,087 | 44 | 1 [reference] | 1 [reference] | 1 [reference] |
| Q2 | 406,250 | 51 | 1.20 [0.80 – 1.80] | 1.23 [0.82 – 1.84] | 1.22 [0.81 – 1.83] |
| Q3 | 405,855 | 47 | 1.13 [0.75 – 1.71] | 1.11 [0.73 – 1.69] | 1.09 [0.71 – 1.66] |
| Q4 | 406,133 | 53 | 1.30 [0.87 – 1.94] | 1.16 [0.76 – 1.76] | 1.13 [0.74 – 1.71] |
| Q5 | 405,909 | 67 | 1.67 [1.14 – 2.45] | 1.22 [0.81 – 1.83] | 1.17 [0.77 – 1.76] |
| P for trend | 0.007 | 0.54 | 0.70 | ||
HR, Hazard ratio; MV, multivariable
Adjusted for age, race (Caucasian vs. non-Caucasian), BMI (kg/m2), smoking (never smoker, past smoker, current smoker 1 – 14 cigarettes per day (CPD), 15 – 25 CPD, and 25+ CPD), alcohol intake (0 g/d, 0.1 – 4.9 g/d, 5.0 – 9.9 g/d, and 10+ g/d), calorie consumption (kcal/day in quintiles), and exercise (METs/week in quintiles).
Adjusted for age, race (Caucasian vs. non-Caucasian), BMI (kg/m2), smoking (never smoker, past smoker, current smoker 1 – 14 cigarettes per day (CPD), 15 – 25 CPD, and 25+ CPD), alcohol intake (0 g/d, 0.1 – 4.9 g/d, 5.0 – 9.9 g/d, and 10+ g/d), calorie consumption (kcal/day in quintiles), and exercise (METs/week in quintiles), cardiovascular disease, hypertension, hypercholesterolemia, and type 2 diabetes.
Table III.
Psoriatic arthritis risk in quintiles of baseline EDIP score stratified by BMI in Nurses’ Health Study II
| EDIP | Person-years | # of cases | Age-adjusted HR (95% CI) | MV-adjusted HR1 (95% CI)† | MV-adjusted HR2 (95% CI)‡ |
|---|---|---|---|---|---|
| BMI < 25kg/m2 | |||||
| Q1 | 235,207 | 12 | 1 [reference] | 1 [reference] | 1 [reference] |
| Q2 | 222,998 | 18 | 1.67 [0.80 – 3.46] | 1.82 [0.87 – 3.82] | 1.81 [0.86 – 3.80] |
| Q3 | 208,175 | 16 | 1.61 [0.76 – 3.42] | 1.82 [0.84 – 3.93] | 1.79 [0.83 – 3.87] |
| Q4 | 185,686 | 13 | 1.51 [0.68 – 3.32] | 1.74 [0.77 – 3.94] | 1.70 [0.75 – 3.86] |
| Q5 | 150,558 | 8 | 1.18 [0.48 – 2.91] | 1.37 [0.54 – 3.52] | 1.32 [0.51 – 3.39] |
| P for trend | 0.74 | 0.55 | 0.61 | ||
| BMI > 25kg/m2 | |||||
| Q1 | 169,242 | 32 | 1 [reference] | 1 [reference] | 1 [reference] |
| Q2 | 181,568 | 33 | 0.99 [0.61 – 1.61] | 1.04 [0.64 – 1.70] | 1.04 [0.63 – 1.69] |
| Q3 | 196,100 | 31 | 0.87 [0.53 – 1.43] | 0.90 [0.55 – 1.50] | 0.89 [0.54 – 1.47] |
| Q4 | 218,890 | 39 | 0.99 [0.62 – 1.58] | 0.97 [0.59 – 1.57] | 0.94 [0.58 – 1.53] |
| Q5 | 253,541 | 58 | 1.28 [0.83 – 1.98] | 1.07 [0.67 – 1.70] | 1.02 [0.64 – 1.63] |
| P for trend | 0.18 | 0.84 | 0.97 | ||
HR, Hazard ratio; MV, multivariable
Adjusted for age, race (Caucasian vs. non-Caucasian), BMI (kg/m2), smoking (never smoker, past smoker, current smoker 1 – 14 cigarettes per day (CPD), 15 – 25 CPD, and 25+ CPD), alcohol intake (0 g/d, 0.1 – 4.9 g/d, 5.0 – 9.9 g/d, and 10+ g/d), calorie consumption (kcal/day in quintiles), and exercise (METs/week in quintiles).
Adjusted for age, race (Caucasian vs. non-Caucasian), BMI (kg/m2), smoking (never smoker, past smoker, current smoker 1 – 14 cigarettes per day (CPD), 15 – 25 CPD, and 25+ CPD), alcohol intake (0 g/d, 0.1 – 4.9 g/d, 5.0 – 9.9 g/d, and 10+ g/d), calorie consumption (kcal/day in quintiles), and exercise (METs/week in quintiles), cardiovascular disease, hypertension, hypercholesterolemia, and type 2 diabetes.
There were 403 cases of atopic dermatitis over 1,130,810 person-years. EDIP scores were not associated with incident atopic dermatitis in the age- or multivariable-adjusted models (all P-trend > 0.05) (Table IV). Sensitivity analyses using more stringent atopic dermatitis definitions were similar to our primary analysis, and stratified analyses found no differential results according to history of asthma (data not shown).
Table IV.
Risk of atopic dermatitis according to quintiles of EDIP score in Nurses’ Health Study II
| EDIP | Person-years | # of cases | Age-adjusted HR (95% CI) | MV-adjusted HR1 (95% CI)† | MV-adjusted HR2 (95% CI)‡ | MV-adjusted HR3 (95% CI)* |
|---|---|---|---|---|---|---|
| Q1 | 226,264 | 84 | 1 [reference] | 1 [reference] | 1 [reference] | 1 [reference] |
| Q2 | 226,318 | 78 | 0.93 [0.68 – 1.27] | 0.95 [0.69 – 1.30] | 0.95 [0.69 – 1.29] | 0.95 [0.69 – 1.30] |
| Q3 | 225,998 | 76 | 0.90 [0.66 – 1.22] | 0.93 [0.67 – 1.28] | 0.93 [0.68 – 1.28] | 0.93 [0.67 – 1.28] |
| Q4 | 226,209 | 85 | 1.01 [0.75 – 1.37] | 1.04 [0.76 – 1.43] | 1.05 [0.76 – 1.44] | 1.04 [0.76 – 1.43] |
| Q5 | 226,021 | 80 | 0.95 [0.69 – 1.29] | 0.96 [0.69 – 1.34] | 0.96 [0.69 – 1.35] | 0.96 [0.68 – 1.34] |
| P for trend | 0.94 | 0.98 | 0.95 | 0.99 |
HR, Hazard ratio; MV, multivariable
Adjusted for age, race (Caucasian vs. non-Caucasian), BMI (kg/m2), smoking (never smoker, past smoker, current smoker 1 – 14 cigarettes per day (CPD), 15 – 25 CPD, and 25+ CPD), alcohol intake (0 g/d, 0.1 – 4.9 g/d, 5.0 – 9.9 g/d, and 10+ g/d), calorie consumption (kcal/day in quintiles), and exercise (METs/week in quintiles).
Adjusted for age, race (Caucasian vs. non-Caucasian), BMI (kg/m2), smoking (never smoker, past smoker, current smoker 1 – 14 cigarettes per day (CPD), 15 – 25 CPD, and 25+ CPD), alcohol intake (0 g/d, 0.1 – 4.9 g/d, 5.0 – 9.9 g/d, and 10+ g/d), calorie consumption (kcal/day in quintiles), and exercise (METs/week in quintiles), cardiovascular disease, hypertension, hypercholesterolemia, and type 2 diabetes.
Adjusted for age, race (Caucasian vs. non-Caucasian), BMI (kg/m2), smoking (never smoker, past smoker, current smoker 1 – 14 cigarettes per day (CPD), 15 – 25 CPD, and 25+ CPD), alcohol intake (0 g/d, 0.1 – 4.9 g/d, 5.0 – 9.9 g/d, and 10+ g/d), calorie consumption (kcal/day in quintiles), and exercise (METs/week in quintiles), cardiovascular disease, hypertension, hypercholesterolemia, type 2 diabetes and asthma
Conclusions
In this large retrospective cohort study of US women, we did not find any association between a pro-inflammatory diet and increased risk of incident psoriasis, psoriatic arthritis or atopic dermatitis. In our age-adjusted model, pro-inflammatory dietary patterns were associated with psoriatic arthritis, but the HR was attenuated and no longer statistically significant once we adjusted for important confounders, particularly BMI. For atopic dermatitis, no significant relationship was found with pro-inflammatory diet. Though we found no convincing evidence for an association with EDIP score for any of the investigated diseases, the results followed an internal pattern consistent with our hypotheses that higher EDIP scores would have more of an association with psoriatic disease than with atopic dermatitis.
Previous studies have shown robust associations between psoriatic disease and inflammatory bowel disease, cardiovascular disease, and metabolic syndrome.51–56 Like psoriasis and psoriatic arthritis, these diseases share elevated serum inflammatory biomarkers such as CRP, TNF-α, and IL-6.38–41 Recently, the association between Mediterranean diet and psoriasis was assessed in the French NutriNet-Santé study.57 Researchers found that low adherence to a Mediterranean diet, which has pro-inflammatory effects similar to those measured with the EDIP,25–28 was associated with increased odds of severe but not milder psoriasis. Those results are consistent with evidence showing that a diet with anti-inflammatory properties has beneficial health effects such as reduced systemic inflammation,58 metabolic syndrome,59, 60 and cardiovascular events.61 The divergent results between that study and ours are likely related to important methodological differences, specifically that psoriasis was classified by severity in the NutriNet-Santé study whereas we examined the risk of incident psoriasis overall.57 The inflammatory potential of diet may not be as crucial for psoriatic disease incidence compared to other lifestyle risks and genetic factors.62, 63 Currently, the strongest recommendation for dietary change in psoriatic disease is weight loss.64
We did not find evidence of a relationship between pro-inflammatory diet and incident atopic dermatitis which, like psoriasis, has a strong genetic component.65 Furthermore, unlike psoriasis and psoriatic arthritis, atopic dermatitis is not as strongly associated with Th1- associated inflammation66 though new evidence is emerging of associations between atopic dermatitis, obesity, and cardiovascular risk factors.11, 67 Additionally, one study found CRP levels to be elevated in patients with more severe atopic dermatitis.68 Overall, though, we found no evidence that a diet with pro-inflammatory properties, in particular one associated with increased levels of IL-6, CRP, and TNF-α, increased atopic dermatitis risk. It is possible that a dietary index associated more with Th-2 inflammation would yield different results.
There are several important strengths and limitations to our study. We had a large sample size, prospectively collected dietary and psoriatic disease data, and were able to adjust for important confounders. However, given that participants were US women, our results may not be generalizable to other populations. Further, we examined adult-onset atopic dermatitis, and so our results may not be applicable for more classic, childhood-onset disease. Questionnaire-based diagnoses, though validated, are subject to misclassification, as is the year of atopic dermatitis diagnosis. It is likely that dilution of the case pool with false-positive cases would bias our results towards the null. Most NHS-II participants with psoriasis and atopic dermatitis have mild disease;49 longitudinal investigation of an inflammatory diet’s impact on disease severity over time would be interesting, but is not possible within our dataset. Finally, as in any observational study, there may be residual confounding by unmeasured factors.
In conclusion, a pro-inflammatory diet did not substantially modify the risk for psoriasis, psoriatic arthritis or atopic dermatitis among women in this study. While a pro-inflammatory diet may be associated with other health risks,69, 70 we found no reason to counsel patients about a potential impact on psoriatic disease or atopic dermatitis.
Capsule Summary.
Diet is an important modulator of systemic inflammation and may play a role in the development and progression of inflammatory skin diseases.
Our findings do not support dietary modification to decrease inflammatory potential as a preventive measure in patients at risk for the psoriasis, psoriatic arthritis, or atopic dermatitis.
Funding sources:
This study was funded by the Brown University Department of Dermatology and an investigator-initiated grant from Regeneron and Sanofi (Qureshi), from the National Institute of Health (CA207736 and CA176726), and R00CA207736 from the National Cancer Institute.
Abbreviations:
- NHS-II
Nurses’ Health Study II
- EDIP
empirical dietary inflammatory pattern
- CRP
C-reactive protein
- IL-6
interleukin-6
- TNF-α
tumor necrosis factor-alpha
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Conflicts of interest: In the last three years, Dr. Drucker served as an investigator and has received research funding from Sanofi and Regeneron and has been a consultant for Sanofi, RTI Health Solutions, Eczema Society of Canada and Canadian Agency for Drugs and Technology in Health. He has received honoraria from Prime Inc, Spire Learning, CME Outfitters and Eczema Society of Canada. His institution receives education grants from Sanofi. Dr. Qureshi has served as a consultant (honoraria donated to charity) for Eli Lilly, Amgen, Centers for Disease Control, Janssen, Merck, Novartis and Pfizer, has been an investigator (non-compensation) for Sanofi and has a patent pending for Nix-Tix tick remover.
References
- 1.Helmick CG, Lee-Han H, Hirsch SC et al. Prevalence of psoriasis among adults in the U.S.: 2003–2006 and 2009–2010 National Health and Nutrition Examination Surveys. Am J Prev Med 2014;47:37–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Rachakonda TD, Schupp CW , Armstrong AW. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol 2014;70:512–6. [DOI] [PubMed] [Google Scholar]
- 3.Silverberg JI, Garg NK, Paller AS et al. Sleep disturbances in adults with eczema are associated with impaired overall health: a US population-based study. J Invest Dermatol 2015;135:56–66. [DOI] [PubMed] [Google Scholar]
- 4.Barbarot S, Auziere S, Gadkari A et al. Epidemiology of atopic dermatitis in adults: Results from an international survey. Allergy 2018;73:1284–93. [DOI] [PubMed] [Google Scholar]
- 5.Mease PJ, Gladman DD, Papp KA et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol 2013;69:729–35. [DOI] [PubMed] [Google Scholar]
- 6.Boehncke WH. Etiology and Pathogenesis of Psoriasis. Rheum Dis Clin North Am 2015;41:665–75. [DOI] [PubMed] [Google Scholar]
- 7.Barnas JL , Ritchlin CT. Etiology and Pathogenesis of Psoriatic Arthritis. Rheum Dis Clin North Am 2015;41:643–63. [DOI] [PubMed] [Google Scholar]
- 8.Ong PY. New insights in the pathogenesis of atopic dermatitis. Pediatr Res 2014;75:171–5. [DOI] [PubMed] [Google Scholar]
- 9.Debbaneh M, Millsop JW, Bhatia BK et al. Diet and psoriasis, part I: Impact of weight loss interventions. J Am Acad Dermatol 2014;71:133–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Labitigan M, Bahce-Altuntas A, Kremer JM et al. Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis. Arthritis Care Res (Hoboken) 2014;66:600–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Zhang A , Silverberg JI. Association of atopic dermatitis with being overweight and obese: a systematic review and metaanalysis. Journal of the American Academy of Dermatology 2015;72:606–16 e4. [DOI] [PubMed] [Google Scholar]
- 12.Armstrong AW, Harskamp CT, Dhillon JS et al. Psoriasis and smoking: a systematic review and meta-analysis. Br J Dermatol 2014;170:304–14. [DOI] [PubMed] [Google Scholar]
- 13.Bremander A, Jacobsson LT, Bergman S et al. Smoking is associated with a worse self- reported health status in patients with psoriatic arthritis: data from a Swedish population-based cohort. Clin Rheumatol 2015;34:579–83. [DOI] [PubMed] [Google Scholar]
- 14.Tillett W, Jadon D, Shaddick G et al. Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis. Ann Rheum Dis 2013;72:1358–61. [DOI] [PubMed] [Google Scholar]
- 15.Kantor R, Kim A, Thyssen JP et al. Association of atopic dermatitis with smoking: A systematic review and meta-analysis. Journal of the American Academy of Dermatology 2016;75:1119–25 e1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Basavaraj KH, Navya MA , Rashmi R. Stress and quality of life in psoriasis: an update. Int J Dermatol 2011;50:783–92. [DOI] [PubMed] [Google Scholar]
- 17.Kwon JA, Park EC, Lee M et al. Does stress increase the risk of atopic dermatitis in adolescents? results of the Korea Youth Risk Behavior Web-based Survey (KYRBWS-VI). PLoS One 2013;8:e67890. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Minihane AM, Vinoy S, Russell WR et al. Low-grade inflammation, diet composition and health: current research evidence and its translation. Br J Nutr 2015;114:999–1012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Ilich JZ, Kelly OJ, Kim Y et al. Low-grade chronic inflammation perpetuated by modern diet as a promoter of obesity and osteoporosis. Arh Hig Rada Toksikol 2014;65:139–48. [DOI] [PubMed] [Google Scholar]
- 20.Navarro SL, Kantor ED, Song X et al. Factors Associated with Multiple Biomarkers of Systemic Inflammation. Cancer Epidemiol Biomarkers Prev 2016;25:521–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Krintus M, Kozinski M, Kubica J et al. Critical appraisal of inflammatory markers in cardiovascular risk stratification. Crit Rev Clin Lab Sci 2014;51:263–79. [DOI] [PubMed] [Google Scholar]
- 22.Guina T, Biasi F, Calfapietra S et al. Inflammatory and redox reactions in colorectal carcinogenesis. Ann N Y Acad Sci 2015;1340:95–103. [DOI] [PubMed] [Google Scholar]
- 23.Donath MY , Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011;11:98–107. [DOI] [PubMed] [Google Scholar]
- 24.Fardet A , Boirie Y. Associations between food and beverage groups and major diet-related chronic diseases: an exhaustive review of pooled/meta-analyses and systematic reviews. Nutr Rev 2014;72:741–62. [DOI] [PubMed] [Google Scholar]
- 25.Schwingshackl L , Hoffmann G. Mediterranean dietary pattern, inflammation and endothelial function: a systematic review and meta-analysis of intervention trials. Nutr Metab Cardiovasc Dis 2014;24:929–39. [DOI] [PubMed] [Google Scholar]
- 26.Schwingshackl L, Missbach B, Konig J et al. Adherence to a Mediterranean diet and risk of diabetes: a systematic review and meta-analysis. Public Health Nutr 2015;18:1292–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Schwingshackl L , Hoffmann G. Adherence to Mediterranean diet and risk of cancer: an updated systematic review and meta-analysis of observational studies. Cancer Med 2015;4:1933–47. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Schwingshackl L , Hoffmann G. Adherence to Mediterranean diet and risk of cancer: a systematic review and meta-analysis of observational studies. Int J Cancer 2014;135:1884–97. [DOI] [PubMed] [Google Scholar]
- 29.Calle MC , Fernandez ML. Inflammation and type 2 diabetes. Diabetes Metab 2012;38:183–91. [DOI] [PubMed] [Google Scholar]
- 30.Lontchi-Yimagou E, Sobngwi E, Matsha TE et al. Diabetes mellitus and inflammation. Curr Diab Rep 2013;13:435–44. [DOI] [PubMed] [Google Scholar]
- 31.Maru GB, Gandhi K, Ramchandani A et al. The role of inflammation in skin cancer. Adv Exp Med Biol 2014;816:437–69. [DOI] [PubMed] [Google Scholar]
- 32.Wu Y, Antony S, Meitzler JL et al. Molecular mechanisms underlying chronic inflammation- associated cancers. Cancer Lett 2014;345:164–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Francescone R, Hou V , Grivennikov SI. Microbiome, inflammation, and cancer. Cancer J 2014;20:181–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Tabung FK, Smith-Warner SA, Chavarro JE et al. Development and Validation of an Empirical Dietary Inflammatory Index. J Nutr 2016;146:1560–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Tabung FK, Smith-Warner SA, Chavarro JE et al. An Empirical Dietary Inflammatory Pattern Score Enhances Prediction of Circulating Inflammatory Biomarkers in Adults. J Nutr 2017;147:1567–77. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Tabung FK, Giovannucci EL, Giulianini F et al. An Empirical Dietary Inflammatory Pattern Score Is Associated with Circulating Inflammatory Biomarkers in a Multi-Ethnic Population of Postmenopausal Women in the United States. J Nutr 2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Dowlatshahi EA, van der Voort EA, Arends LR et al. Markers of systemic inflammation in psoriasis: a systematic review and meta-analysis. Br J Dermatol 2013;169:266–82. [DOI] [PubMed] [Google Scholar]
- 38.Marques-Vidal P, Bastardot F, von Kanel R et al. Association between circulating cytokine levels, diabetes and insulin resistance in a population-based sample (CoLaus study). Clin Endocrinol (Oxf) 2013;78:232–41. [DOI] [PubMed] [Google Scholar]
- 39.Kablak-Ziembicka A, Przewlocki T, Sokolowski A et al. Carotid intima-media thickness, hs- CRP and TNF-alpha are independently associated with cardiovascular event risk in patients with atherosclerotic occlusive disease. Atherosclerosis 2011;214:185–90. [DOI] [PubMed] [Google Scholar]
- 40.Kablak-Ziembicka A, Przewlocki T, Stepien E et al. Relationship between carotid intima-media thickness, cytokines, atherosclerosis extent and a two-year cardiovascular risk in patients with arteriosclerosis. Kardiol Pol 2011;69:1024–31. [PubMed] [Google Scholar]
- 41.Fengming Y , Jianbing W. Biomarkers of inflammatory bowel disease. Dis Markers 2014;2014:710915. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Mu Z, Zhao Y, Liu X et al. Molecular biology of atopic dermatitis. Clin Rev Allergy Immunol 2014;47:193–218. [DOI] [PubMed] [Google Scholar]
- 43.Marcotorchino J, Romier B, Gouranton E et al. Lycopene attenuates LPS-induced TNF-alpha secretion in macrophages and inflammatory markers in adipocytes exposed to macrophage- conditioned media. Mol Nutr Food Res 2012;56:725–32. [DOI] [PubMed] [Google Scholar]
- 44.Gartner C, Stahl W , Sies H. Lycopene is more bioavailable from tomato paste than from fresh tomatoes. Am J Clin Nutr 1997;66:116–22. [DOI] [PubMed] [Google Scholar]
- 45.Tabung FK, Wang W, Fung TT et al. Development and validation of empirical indices to assess the insulinaemic potential of diet and lifestyle. Br J Nutr 2016:1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Joseph SV, Edirisinghe I , Burton-Freeman BM. Fruit Polyphenols: A Review of Anti- inflammatory Effects in Humans. Crit Rev Food Sci Nutr 2016;56:419–44. [DOI] [PubMed] [Google Scholar]
- 47.Dominguez PL, Husni ME, Holt EW et al. Validity, reliability, and sensitivity-to-change properties of the psoriatic arthritis screening and evaluation questionnaire. Arch Dermatol Res 2009;301:573–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Husni ME, Meyer KH, Cohen DS et al. The PASE questionnaire: pilot-testing a psoriatic arthritis screening and evaluation tool. J Am Acad Dermatol 2007;57:581–7. [DOI] [PubMed] [Google Scholar]
- 49.Drucker AM, Cho E, Li WQ et al. Diagnosis validation and clinical characterization of atopic dermatitis in Nurses’ Health Study 2. Journal of the European Academy of Dermatology & Venereology 2018;In Press [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Chen CA, Lin L, Tsibris HC et al. Pilot testing and validation of an atopic dermatitis screening and evaluation questionnaire. International journal of dermatology 2016. [DOI] [PubMed] [Google Scholar]
- 51.Grozdev I, Korman N , Tsankov N. Psoriasis as a systemic disease. Clin Dermatol 2014;32:343–50. [DOI] [PubMed] [Google Scholar]
- 52.Skroza N, Proietti I, Pampena R et al. Correlations between psoriasis and inflammatory bowel diseases. Biomed Res Int 2013;2013:983902. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Alpsoy S, Akyuz A, Erfan G et al. Atherosclerosis, some serum inflammatory markers in psoriasis. G Ital Dermatol Venereol 2014;149:167–75. [PubMed] [Google Scholar]
- 54.Baeta IG, Bittencourt FV, Gontijo B et al. Comorbidities and cardiovascular risk factors in patients with psoriasis. An Bras Dermatol 2014;89:735–44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Shlyankevich J, Mehta NN, Krueger JG et al. Accumulating evidence for the association and shared pathogenic mechanisms between psoriasis and cardiovascular-related comorbidities. Am J Med 2014;127:1148–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Jacobi A, Kupke C, Behzad M et al. Comorbidities, metabolic risk profile and health-related quality of life in German patients with plaque-type psoriasis: a cross-sectional prospective study. Int J Dermatol 2013;52:1081–7. [DOI] [PubMed] [Google Scholar]
- 57.Phan C, Touvier M, Kesse-Guyot E et al. Association Between Mediterranean Anti- inflammatory Dietary Profile and Severity of Psoriasis: Results From the NutriNet-Sante Cohort. JAMA Dermatol 2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Akbaraly TN, Shipley MJ, Ferrie JE et al. Long-term adherence to healthy dietary guidelines and chronic inflammation in the prospective Whitehall II study. Am J Med 2015;128:152–60 e4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Salas-Salvado J, Guasch-Ferre M, Lee CH et al. Protective Effects of the Mediterranean Diet on Type 2 Diabetes and Metabolic Syndrome. J Nutr 2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Esposito K, Kastorini CM, Panagiotakos DB et al. Mediterranean diet and metabolic syndrome: an updated systematic review. Rev Endocr Metab Disord 2013;14:255–63. [DOI] [PubMed] [Google Scholar]
- 61.Esposito K , Giugliano D. Mediterranean diet for primary prevention of cardiovascular disease. N Engl J Med 2013;369:674–5. [DOI] [PubMed] [Google Scholar]
- 62.Chandra A, Ray A, Senapati S et al. Genetic and epigenetic basis of psoriasis pathogenesis. Mol Immunol 2015;64:313–23. [DOI] [PubMed] [Google Scholar]
- 63.O’Rielly DD , Rahman P. Genetic, Epigenetic and Pharmacogenetic Aspects of Psoriasis and Psoriatic Arthritis. Rheum Dis Clin North Am 2015;41:623–42. [DOI] [PubMed] [Google Scholar]
- 64.Ford AR, Siegel M, Bagel J et al. Dietary Recommendations for Adults With Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis Foundation: A Systematic Review. JAMA Dermatol 2018. [DOI] [PubMed] [Google Scholar]
- 65.Hoffjan S , Stemmler S. Unravelling the complex genetic background of atopic dermatitis: from genetic association results towards novel therapeutic strategies. Arch Dermatol Res 2015;307:659–70. [DOI] [PubMed] [Google Scholar]
- 66.Deckert S, Kopkow C , Schmitt J. Nonallergic comorbidities of atopic eczema: an overview of systematic reviews. Allergy 2014;69:37–45. [DOI] [PubMed] [Google Scholar]
- 67.Brunner PM, Silverberg JI, Guttman-Yassky E et al. Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder. The Journal of investigative dermatology 2017;137:18–25. [DOI] [PubMed] [Google Scholar]
- 68.Vekaria AS, Brunner PM, Aleisa AI et al. Moderate-to-severe atopic dermatitis patients show increases in serum C-reactive protein levels, correlating with skin disease activity. F1000Res 2017;6:1712. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Sparks JA, Barbhaiya M, Tedeschi SK et al. Inflammatory dietary pattern and risk of developing rheumatoid arthritis in women. Clin Rheumatol 2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Tabung FK, Liu L, Wang W et al. Association of Dietary Inflammatory Potential With Colorectal Cancer Risk in Men and Women. JAMA Oncol 2018;4:366–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
